| 2 | A | 215328 | 001 | BUDESONIDE | AEROSOL, FOAM;RECTAL | AEROSOL, FOAM | RECTAL | BUDESONIDE | PADAGIS ISRAEL | 2MG/ACTUATION | AB | ["AB"] | 2023-04-12 | Apr 12, 2023 | No | No | Yes | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | f3a4430c87471f63b6428f9a04b2041da1f11e3f1e05bbbe5b4560bdac51397d |
| 3 | N | 205613 | 001 | BUDESONIDE | AEROSOL, FOAM;RECTAL | AEROSOL, FOAM | RECTAL | UCERIS | SALIX | 2MG/ACTUATION | AB | ["AB"] | 2014-10-07 | Oct 7, 2014 | No | Yes | No | RX | SALIX PHARMACEUTICALS INC | ae61428ed274f2bbd4033afbd79d8f63365d254bf4987321ce3e47febf3162c4 |
| 4 | N | 212379 | 001 | MINOCYCLINE HYDROCHLORIDE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | AMZEEQ | JOURNEY | EQ 4% BASE | | [] | 2019-10-18 | Oct 18, 2019 | No | Yes | Yes | RX | JOURNEY MEDICAL CORP | c2d8765c93f697ab94a6b1ee36a52fa12c4f97c5869f48922687c0f2380c653a |
| 5 | A | 210928 | 001 | AZELAIC ACID | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | AZELAIC ACID | TEVA PHARMS USA | 15% | | [] | 2020-10-07 | Oct 7, 2020 | No | No | No | DISCN | TEVA PHARMACEUTICALS USA INC | c95613ff55aef6a83d024437d3c923f6b7358c20a26bdfcb131dc9cd17024211 |
| 6 | A | 215832 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | BETAMETHASONE VALERATE | ALEMBIC | 0.12% | AB | ["AB"] | 2024-08-22 | Aug 22, 2024 | No | No | No | RX | ALEMBIC PHARMACEUTICALS LTD | 785224d50b69cf4305ce04195ae6c2d5279baa5d00ef0b87914644429aa85deb |
| 7 | A | 207144 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | BETAMETHASONE VALERATE | NOVAST LABS | 0.12% | | [] | 2017-05-24 | May 24, 2017 | No | No | No | DISCN | NOVAST LABORATORIES LTD | 879dedbaf966cfcf668fba9e3cc30a6e2524d086b6c5553e678461f2ca6cab0c |
| 8 | A | 078337 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | BETAMETHASONE VALERATE | PADAGIS ISRAEL | 0.12% | AB | ["AB"] | 2012-11-26 | Nov 26, 2012 | No | No | No | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | 99254e6b3052126a19962dee01058a8586a2c71e971a65713b91162fe8e8dcbe |
| 9 | A | 208204 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | BETAMETHASONE VALERATE | TARO | 0.12% | AB | ["AB"] | 2017-05-24 | May 24, 2017 | No | No | Yes | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | ea53705526b4537c9340ca88cd7d48dd882d5f425654469a382a0759912831a2 |
| 10 | A | 210639 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | BETAMETHASONE VALERATE | XIROMED | 0.12% | AB | ["AB"] | 2023-04-18 | Apr 18, 2023 | No | No | No | RX | XIROMED PHARMA ESPANA SL | 58997035dde1cb484c7fa985e7f36cd9d0e05b87a2796662d032de89a886102f |
| 11 | A | 214688 | 001 | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE | GLENMARK PHARMS LTD | 0.064%;0.005% | | [] | 2023-03-21 | Mar 21, 2023 | No | No | No | DISCN | GLENMARK PHARMACEUTICALS LTD | dd4c0f7414d9d41ccde8c0559058a623ce2e739fccdaecb60f1f12f9d7a5a4bf |
| 12 | A | 210778 | 001 | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLINDAMYCIN PHOSPHATE | GLENMARK PHARMS LTD | 1% | AT | ["AT"] | 2021-09-20 | Sep 20, 2021 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 36bbfcc496eb8a4d06f61de1d8f0f709d2077ded246410b884548f236ebdd9f0 |
| 13 | A | 090785 | 001 | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLINDAMYCIN PHOSPHATE | PADAGIS ISRAEL | 1% | AT | ["AT"] | 2010-03-31 | Mar 31, 2010 | No | No | Yes | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | 3284d71caa223a76ee109bc998134d2c0a008685d91a014ac47c0c4026ecde59 |
| 14 | A | 210004 | 001 | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLINDAMYCIN PHOSPHATE | TARO | 1% | AT | ["AT"] | 2020-03-11 | Mar 11, 2020 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | 9d78fcdc40b7b75ad1def5062f9ecee394e362fbfcd28686170dc728a993bc10 |
| 15 | A | 215838 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | ALEMBIC | 0.05% | AB1 | ["AB1"] | 2022-04-21 | Apr 21, 2022 | No | No | No | RX | ALEMBIC PHARMACEUTICALS LTD | 53488995a1474afdbdcd73e81f55908f71807582f9710e32c7a817ad3e79d5a2 |
| 16 | A | 210809 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | GLENMARK PHARMS LTD | 0.05% | AB1 | ["AB1"] | 2019-02-15 | Feb 15, 2019 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | 90c9a2311aaeea29fcc8e773100051b43d9cacf43025e115127bf88cc506b08c |
| 17 | A | 211450 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | GLENMARK PHARMS LTD | 0.05% | AB2 | ["AB2"] | 2019-09-09 | Sep 9, 2019 | No | No | No | RX | GLENMARK PHARMACEUTICALS LTD | e6b1af0803afa1f36b53b5feed328429c7107547d6f68bf570ab1fde87e5002d |
| 18 | A | 206805 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | NOVAST LABS | 0.05% | | [] | 2017-07-31 | Jul 31, 2017 | No | No | No | DISCN | NOVAST LABORATORIES INC | c1660537d6671a4a5b5be8e026242eaf4262902b727875a9d5e6f282e76ddc39 |
| 19 | A | 077763 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | PADAGIS ISRAEL | 0.05% | AB1 | ["AB1"] | 2008-03-10 | Mar 10, 2008 | No | No | No | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | ac756d1e7e024a1a09ad40d4981afdb4227b385cf673580a0528e3605c8d0c88 |
| 20 | A | 201402 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | PADAGIS ISRAEL | 0.05% | AB2 | ["AB2"] | 2012-08-14 | Aug 14, 2012 | No | No | Yes | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | 47a06c35c78bf174b2a7397815d1bb58c11a2ab09d06971be46b6659f21a8011 |
| 21 | A | 208563 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | TARO | 0.05% | AB2 | ["AB2"] | 2024-03-14 | Mar 14, 2024 | No | No | No | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | d94d44bf7afc245e1db7e4def7f45428f1f71394281132a86754a986b2cc9390 |
| 22 | A | 208779 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | CLOBETASOL PROPIONATE | TARO | 0.05% | AB1 | ["AB1"] | 2018-10-04 | Oct 4, 2018 | No | No | Yes | RX | TARO PHARMACEUTICAL INDUSTRIES LTD | eb3d86e44d3e24524e5edef7da8beee0407620c986fea39070fec27a03f429f3 |
| 23 | N | 205175 | 001 | ECONAZOLE NITRATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | ECOZA | RESILIA PHARMS | 1% | | [] | 2013-10-24 | Oct 24, 2013 | No | Yes | Yes | RX | RESILIA PHARMACEUTICALS INC | c2ca4ae0852a49df07354bfaf4df9a62e55ce5ce9da656483c59256dcb63246b |
| 24 | N | 207589 | 001 | BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | ENSTILAR | LEO PHARMA AS | 0.064%;0.005% | | [] | 2015-10-16 | Oct 16, 2015 | No | Yes | Yes | RX | LEO PHARMA AS | 93200f740f49284bf1500d50f311b2da4693999c7ec9f58fc1d2bfcca0632004 |
| 25 | N | 050801 | 001 | CLINDAMYCIN PHOSPHATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | EVOCLIN | NORVIUM BIOSCIENCE | 1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | | [] | 2004-10-22 | Oct 22, 2004 | No | Yes | No | DISCN | NORVIUM BIOSCIENCE LLC | 5ee298c1fe5ecbbed16d73d0015fcbeb6303304692cdfbb9df511e751a15d081 |
| 26 | N | 021738 | 001 | KETOCONAZOLE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | EXTINA | NORVIUM BIOSCIENCE | 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | | [] | 2007-06-12 | Jun 12, 2007 | No | Yes | No | DISCN | NORVIUM BIOSCIENCE LLC | 22965393e2e6ebba0294b7b25c1567bb2565847f9cf645babfc8d94fbc55f997 |
| 27 | N | 202428 | 001 | TAZAROTENE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | FABIOR | MAYNE PHARMA | 0.1% | | [] | 2012-05-11 | May 11, 2012 | No | Yes | Yes | RX | MAYNE PHARMA LLC | 72c78eee5a9dd0ce197129a158a10847a777cba5e0f4347cbb7219408d672c8a |
| 28 | N | 207071 | 001 | AZELAIC ACID | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | FINACEA | LEO PHARMA AS | 15% | | [] | 2015-07-29 | Jul 29, 2015 | No | Yes | Yes | RX | LEO PHARMA AS | c5b149ef4c20f3306dd399c7b4e17f7ff261e4b685fad189afbbe6094bf737d1 |
| 29 | A | 215266 | 001 | HALOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | HALOBETASOL PROPIONATE | PADAGIS ISRAEL | 0.05% | AB | ["AB"] | 2023-08-11 | Aug 11, 2023 | No | No | No | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | 41de6ae783842ff9f1a9be8e21247212be716ba2cd99f62f9fcb3a30a2cff28d |
| 30 | A | 091550 | 001 | KETOCONAZOLE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | KETOCONAZOLE | PADAGIS ISRAEL | 2% | AB | ["AB"] | 2011-08-25 | Aug 25, 2011 | No | No | No | RX | PADAGIS ISRAEL PHARMACEUTICALS LTD | 8d201a8ac3a646f3bc6eb3ac44594d56e0219a244b44119e354d41f777746e02 |
| 31 | A | 213601 | 001 | KETOCONAZOLE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | KETOCONAZOLE | XIROMED | 2% | AB | ["AB"] | 2021-05-21 | May 21, 2021 | No | No | Yes | RX | XIROMED PHARMA ESPANA SL | cc024c28013c6c645358f4e56d2a7ccc16b3e8b72b7caf41c1f172b4f18bf161 |
| 32 | N | 210566 | 001 | HALOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | LEXETTE | MAYNE PHARMA | 0.05% | AB | ["AB"] | 2018-05-24 | May 24, 2018 | No | Yes | Yes | RX | MAYNE PHARMA LLC | b8fe134d20be1ce016a6012aeffa7a009735b1337eff5a1d0a19484f66729080 |
| 33 | N | 020934 | 001 | BETAMETHASONE VALERATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | LUXIQ | PHARMOBEDIENT | 0.12% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | | [] | 1999-02-28 | Feb 28, 1999 | No | Yes | No | DISCN | PHARMOBEDIENT CONSULTING LLC | ec01fa17f0383c86900179c25edbe65b3c791ce257b43fcc919a706f5c467f00 |
| 34 | N | 021812 | 001 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MEN'S ROGAINE | KENVUE BRANDS | 5% | | [] | 2006-01-20 | Jan 20, 2006 | No | Yes | Yes | OTC | KENVUE BRANDS LLC | 8c452e4f73270b96458579a60839a3434a334513fc472358198e1b28aea85e98 |
| 35 | A | 091344 | 001 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL | PERRIGO PHARMA INTL | 5% | | [] | 2011-04-28 | Apr 28, 2011 | No | No | No | OTC | PERRIGO PHARMA INTERNATIONAL DAC | c926f12f8112ae85cdec32d8257c3d191cd8c6b59974fae83ace44b558df6bd7 |
| 36 | A | 218616 | 001 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR MEN) | AUROBINDO PHARMA | 5% | | [] | 2024-04-22 | Apr 22, 2024 | No | No | No | OTC | AUROBINDO PHARMA LTD | a88902687959618270dc99b82617393a6bd404880222bcbe3a5ea42ed334d237 |
| 37 | A | 208092 | 001 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR MEN) | P AND L | 5% | | [] | 2017-02-17 | Feb 17, 2017 | No | No | No | OTC | P AND L DEVELOPMENT LLC | fba35591d677b959847fbb588e9825dba42d9620d79bc0c538013cf4189183f4 |
| 38 | A | 209074 | 001 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR MEN) | TARO | 5% | | [] | 2018-12-31 | Dec 31, 2018 | No | No | No | OTC | TARO PHARMACEUTICAL INDUSTRIES LTD | f8b884720272b6185418316affabca062a15c0dbcbf5bfbc25c022dfad63455d |
| 39 | A | 218616 | 002 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR WOMEN) | AUROBINDO PHARMA | 5% | | [] | 2024-04-22 | Apr 22, 2024 | No | No | No | OTC | AUROBINDO PHARMA LTD | 7d5483d2975a8b29efb7f1792e1484473942f3f998fe0e007d0304f6606af466 |
| 40 | A | 208092 | 002 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR WOMEN) | P AND L | 5% | | [] | 2017-07-27 | Jul 27, 2017 | No | No | No | OTC | P AND L DEVELOPMENT LLC | e311aad88f4445c502a1dfaecb3c36c0d44d5ae702e34ef559a4d90dfa9be139 |
| 41 | A | 209074 | 002 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | MINOXIDIL (FOR WOMEN) | TARO | 5% | | [] | 2019-04-22 | Apr 22, 2019 | No | No | No | OTC | TARO PHARMACEUTICAL INDUSTRIES LTD | 3f72c55683d6aeae4eb8998cdeb9b5ad482d44b8298ca012e53cc9ab0bb28a50 |
| 42 | N | 021142 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | OLUX | PHARMOBEDIENT | 0.05% | | [] | 2000-05-26 | May 26, 2000 | No | Yes | No | DISCN | PHARMOBEDIENT CONSULTING LLC | c9ae094a4e590f25678c328ca19a11cb1b9e479b2cdc4735c7833fb7632df0fb |
| 43 | N | 022013 | 001 | CLOBETASOL PROPIONATE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | OLUX E | PHARMOBEDIENT | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | | [] | 2007-01-12 | Jan 12, 2007 | No | Yes | No | DISCN | PHARMOBEDIENT CONSULTING LLC | f2ae7ba72faeba1af642e238089d98880d5e11b6c0869e09edc28668dfe698c6 |
| 44 | N | 022563 | 001 | CALCIPOTRIENE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | SORILUX | MAYNE PHARMA | 0.005% | | [] | 2010-10-06 | Oct 6, 2010 | No | Yes | Yes | RX | MAYNE PHARMA LLC | b845f551ab306c625ba76f23fb727bbfa2cac500f1eb7d9469e63f7e3d79fafe |
| 45 | N | 021978 | 001 | DESONIDE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | VERDESO | ALMIRALL | 0.05% | | [] | 2006-09-19 | Sep 19, 2006 | No | Yes | No | DISCN | ALMIRALL LLC | 68cf3fb91819387aa40e0a74ca5d86da4ba1aba896c402b6f9d9d9690883db2b |
| 46 | N | 021812 | 002 | MINOXIDIL | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | WOMEN'S ROGAINE | KENVUE BRANDS | 5% | | [] | 2014-02-28 | Feb 28, 2014 | No | Yes | Yes | OTC | KENVUE BRANDS LLC | 215b66abdd8f8f0cf51bf0f6fdbdadacc6384cdf73e36729c8e7da4ef5655d3b |
| 47 | N | 213690 | 001 | MINOCYCLINE HYDROCHLORIDE | AEROSOL, FOAM;TOPICAL | AEROSOL, FOAM | TOPICAL | ZILXI | JOURNEY | EQ 1.5% BASE | | [] | 2020-05-28 | May 28, 2020 | No | Yes | Yes | RX | JOURNEY MEDICAL CORP | 813ae2c7f1be789aa6c1ea812222dc6cabf9000972ab2d8643c0fa2114db752f |
| 48 | N | 021254 | 001 | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | AEROSOL, METERED;INHALATION | AEROSOL, METERED | INHALATION | ADVAIR HFA | GLAXO GRP LTD | 0.045MG/INH;EQ 0.021MG BASE/INH | | [] | 2006-06-08 | Jun 8, 2006 | No | Yes | Yes | RX | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 1c4810307ba521b73ee98d3cb9dae844066cceac8110e16878182b40711612dd |
| 49 | N | 021254 | 002 | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | AEROSOL, METERED;INHALATION | AEROSOL, METERED | INHALATION | ADVAIR HFA | GLAXO GRP LTD | 0.115MG/INH;EQ 0.021MG BASE/INH | | [] | 2006-06-08 | Jun 8, 2006 | No | Yes | Yes | RX | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 9ace23c8cec8cc31ddad61cb6ae4572c111228b8a0020fe6afae19b39c80d234 |
| 50 | N | 021254 | 003 | FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE | AEROSOL, METERED;INHALATION | AEROSOL, METERED | INHALATION | ADVAIR HFA | GLAXO GRP LTD | 0.23MG/INH;EQ 0.021MG BASE/INH | | [] | 2006-06-08 | Jun 8, 2006 | No | Yes | Yes | RX | GLAXO GROUP LTD ENGLAND DBA GLAXOSMITHKLINE | 49196ed0d7130035af4d9572562375f1ea68e961e95df77856374449cdff2be6 |
| 51 | N | 018340 | 001 | FLUNISOLIDE | AEROSOL, METERED;INHALATION | AEROSOL, METERED | INHALATION | AEROBID | ROCHE PALO | 0.25MG/INH | | [] | 1984-08-17 | Aug 17, 1984 | No | No | No | DISCN | ROCHE PALO ALTO LLC | 544314598a82698a6d4d4afabf3a6696ecf2960e1e93275616e48ab271ed419c |